Purchases and Sales Made in Q4 2023 in Aquestive Therapeutics, Inc. (AQST)
This table provides information about the institutional ownership of Aquestive Therapeutics, Inc. (AQST) during Q4 2023. The information is specifically focused on institutions that hold shares of Aquestive Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 07, 2024
Q4 2023
|
Essex Investment Management CO LLC
Boston, MA |
BUY
|
- |
846KNew |
$1.09M - $2.09M
|
846K
$3.91M
|
|
|
Jan 16, 2024
Q4 2023
|
Legato Capital Management LLC
|
BUY
|
- |
341KNew |
$439K - $841K
|
341K
$1.57M
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
190K+ 11.21% |
$246K - $470K
|
1.89M
$8.73M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
165K+ 6103.96% |
$213K - $408K
|
168K
$775K
|
|
|
Feb 14, 2024
Q4 2023
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
156KNew |
$201K - $386K
|
156K
$721K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
142K+ 12.6% |
$184K - $352K
|
1.27M
$5.87M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
96.1K+ 135.17% |
$124K - $237K
|
167K
$772K
|
|
|
Feb 14, 2024
Q4 2023
|
683 Capital Management, LLC
New York, NY |
BUY
|
- |
93.5KNew |
$121K - $231K
|
93.5K
$432K
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
BUY
|
- |
82.2KNew |
$106K - $203K
|
82.2K
$380K
|
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
66.5K+ 1109016.62% |
$85.8K - $164K
|
66.5K
$307K
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
50.8K+ 21352.1% |
$65.6K - $126K
|
51.1K
$236K
|
|
|
Feb 14, 2024
Q4 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
45K+ 30.44% |
$58.1K - $111K
|
193K
$891K
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
38.3K+ 8.4% |
$49.5K - $94.7K
|
495K
$2.29M
|
|
|
Feb 14, 2024
Q4 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
35KNew |
$45.1K - $86.4K
|
35K
$162K
|
|
|
Feb 26, 2024
Q4 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
32.2KNew |
$41.5K - $79.5K
|
32.2K
$149K
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
30.5KNew |
$39.3K - $75.3K
|
30.5K
$141K
|
|
|
Feb 07, 2024
Q4 2023
|
Jump Financial, LLC
Chicago, IL |
BUY
|
- |
29.8KNew |
$38.5K - $73.6K
|
29.8K
$138K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
26K+ 213.15% |
$33.6K - $64.3K
|
38.3K
$177K
|
|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
25.7K+ 39.22% |
$33.1K - $63.5K
|
91.2K
$421K
|
|
|
Feb 13, 2024
Q4 2023
|
Y Intercept (Hong Kong) LTD
|
BUY
|
- |
23.6KNew |
$30.4K - $58.2K
|
23.6K
$109K
|
|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
14.2K+ 10.34% |
$18.3K - $35.1K
|
152K
$700K
|
|
|
Feb 09, 2024
Q4 2023
|
Connor, Clark & Lunn Investment Management Ltd.
|
BUY
|
- |
13.8K+ 5.55% |
$17.8K - $34K
|
262K
$1.21M
|
|
|
Feb 14, 2024
Q4 2023
|
Lazard Asset Management LLC
New York, NY |
BUY
|
- |
12.7K+ 1663.84% |
$16.4K - $31.5K
|
13.5K
$62.4K
|
|
|
Jan 23, 2024
Q4 2023
|
Trust Point Inc.
La Crosse, WI |
BUY
|
- |
10KNew |
$13K - $24.8K
|
10K
$46.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
8.71KNew |
$11.2K - $21.5K
|
8.71K
$40.2K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
8.23K+ 51.63% |
$10.6K - $20.3K
|
24.2K
$112K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
2.29KNew |
$2.95K - $5.66K
|
2.29K
$10.6K
|
|
|
Feb 12, 2024
Q4 2023
|
High Tower Advisors, LLC
Chicago, IL |
BUY
|
- |
500+ 0.38% |
$645 - $1.24K
|
131K
$604K
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
204+ 9.09% |
$263 - $504
|
2.45K
$11.3K
|
|
|
Feb 09, 2024
Q4 2023
|
Parallel Advisors, LLC
|
BUY
|
- |
100New |
$129 - $247
|
100
$462
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
48+ 0.34% |
$61.9 - $119
|
14.3K
$66.2K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Coppell Advisory Solutions LLC
Coppell, TX |
SELL
|
- |
-21- 56.76% |
$27.1 - $51.9
|
16
$73.9
|
|
|
Feb 08, 2024
Q4 2023
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-500- 2.6% |
$645 - $1.24K
|
18.7K
$86.5K
|
|
|
Jan 16, 2024
Q4 2023
|
D.B. Root & Company, LLC
|
SELL
|
- |
-1.5K- 11.58% |
$1.94K - $3.71K
|
11.5K
$52.9K
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.95K- 0.41% |
$2.51K - $4.81K
|
478K
$2.21M
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-3.3K- 10.96% |
$4.26K - $8.15K
|
26.8K
$124K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-6.52K- 59.94% |
$8.41K - $16.1K
|
4.36K
$20.1K
|
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-21.9K- 7.05% |
$28.3K - $54.2K
|
289K
$1.33M
|
|
|
Feb 14, 2024
Q4 2023
|
Occudo Quantitative Strategies LP
Fort Lauderdale, FL |
SELL
|
- |
-24.6K- 41.05% |
$31.7K - $60.7K
|
35.3K
$163K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-29.4K- 18.88% |
$37.9K - $72.5K
|
126K
$583K
|
|
|
Oct 21, 2024
Q4 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-101K- 77.23% |
$130K - $250K
|
29.8K
$138K
|
|
|
Jan 24, 2024
Q4 2023
|
Vahanian & Associates Financial Planning Inc.
|
SELL
|
- |
-131K- 18.07% |
$168K - $322K
|
592K
$2.73M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-192K- 59.6% |
$248K - $475K
|
130K
$603K
|
|
|
Feb 09, 2024
Q4 2023
|
Ci Private Wealth, LLC
Miami, FL |
SELL
|
- |
-266K- 58.1% |
$343K - $656K
|
192K
$885K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-532K- 95.65% |
$686K - $1.31M
|
24.2K
$112K
|
|
|
Feb 13, 2024
Q4 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-876K- 18.25% |
$1.13M - $2.16M
|
3.92M
$18.1M
|